FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
1-Year Est. Return
52.94%
1 Year Est. Return
+52.94%
AUM
$2.5B
AUM Growth
+$313M
(+14%)
Holding
55
Top Buys
| 1 | +$33.5M | |
| 2 | +$31.9M | |
| 3 | +$22.6M | |
| 4 |
Evolus
EOLS
|
+$22.4M |
| 5 |
Akero Therapeutics
AKRO
|
+$19.6M |
Top Sells
| 1 | +$36M | |
| 2 | +$35.7M | |
| 3 | +$15.7M | |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$7.81M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
+$7.2M |
Sector Composition
| 1 | Healthcare | 99.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mirum Pharmaceuticals
MIRM
$3.74B
| $346M | 13.83% |
6,795,121
|
|
||
|
VRNA
2
DELISTED
Verona Pharma
VRNA
| $320M | 12.8% |
3,383,950
-73,900
|
|
||
3
NewAmsterdam Pharma
NAMS
$4.11B
| $301M | 12.03% |
16,607,074
+490,656
|
|
||
4
BridgeBio Pharma
BBIO
$10.5B
| $164M | 6.56% |
3,800,457
|
|
||
5
Arcutis Biotherapeutics
ARQT
$2.51B
| $138M | 5.54% |
9,874,511
+1,089,227
|
|
||
6
Phathom Pharmaceuticals
PHAT
$944M
| $120M | 4.78% |
12,466,489
+2,357,210
|
|
||
7
Krystal Biotech
KRYS
$5.45B
| $94.6M | 3.78% |
688,460
|
|
||
8
Disc Medicine
IRON
$2.59B
| $87.6M | 3.5% |
1,654,834
-100,000
|
|
||
|
MBX
9
MBX Biosciences
MBX
$616M
| $68.3M | 2.73% |
5,985,347
|
|
||
10
Tarsus Pharmaceuticals
TARS
$3.16B
| $56.6M | 2.26% |
1,397,527
|
|
||
11
Trevi Therapeutics
TRVI
$1.29B
| $56.1M | 2.24% |
10,259,409
|
|
||
|
MAZE
12
Maze Therapeutics
MAZE
$1.25B
| $56M | 2.24% |
4,567,275
+438,274
|
|
||
13
KalVista Pharmaceuticals
KALV
$558M
| $55.3M | 2.21% |
4,887,867
|
|
||
14
Zai Lab
ZLAB
$3.21B
| $45.7M | 1.83% |
1,308,138
+958,138
|
|
||
15
Agios Pharmaceuticals
AGIO
$2.41B
| $42.6M | 1.7% |
1,279,754
+209,900
|
|
||
16
Revolution Medicines
RVMD
$9.29B
| $36.7M | 1.47% |
997,455
|
|
||
17
Ultragenyx Pharmaceutical
RARE
$3.27B
| $35.8M | 1.43% |
983,715
+325,000
|
|
||
18
Aura Biosciences
AURA
$385M
| $31.9M | 1.28% |
+5,100,000
|
|
||
19
Erasca
ERAS
$718M
| $28.9M | 1.15% |
22,729,436
+153,585
|
|
||
20
Alkermes
ALKS
$5.08B
| $28.6M | 1.14% |
1,000,647
+399,518
|
|
||
21
Savara
SVRA
$619M
| $26.1M | 1.05% |
11,462,301
|
|
||
|
MREO
22
Mereo BioPharma
MREO
$318M
| $25.6M | 1.02% |
9,440,112
+1,620,249
|
|
||
23
Ascendis Pharma
ASND
$12.5B
| $23M | 0.92% |
133,333
|
|
||
|
24
Evolus
EOLS
$408M
| $22.4M | 0.9% |
+2,435,550
|
|
||
|
HLVX
25
DELISTED
HilleVax
HLVX
| $21.1M | 0.84% |
10,617,062
|
|